Gumampong, Baby Boy .

HRN: 22-39-29  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2023
AMPICILLIN 250MG (VIAL)
01/11/2023
01/18/2023
IV
90mg
Q12H
T/C Perinatal Asphyxia
Waiting Final Action 
01/11/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
01/11/2023
01/18/2023
IV
9mg
Q24H
T/C Perinatal Asphyxia
Waiting Final Action 
01/13/2023
CEFOTAXIME 500MG (VIAL)
01/13/2023
01/19/2023
IVT
85mg
Q12
Perinatal Asphyxia
Waiting Final Action 
01/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/13/2023
01/19/2023
IVT
25mg Loading Dose Then 13mg
Q24
Perinatal Asphyxia
Waiting Final Action 
01/15/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/15/2023
01/22/2023
IV
170 Mg
Q12
Neonatal Sepsis
Waiting Final Action 
01/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/15/2023
01/22/2023
IV
25 Mg
Q24
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: